Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H17N5O2 |
Molecular Weight | 251.285 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCN1C=NC2=C1C(=O)N(C)C(=O)N2C
InChI
InChIKey=CMKUGKVVUUGBHJ-UHFFFAOYSA-N
InChI=1S/C11H17N5O2/c1-13(2)5-6-16-7-12-9-8(16)10(17)15(4)11(18)14(9)3/h7H,5-6H2,1-4H3
Molecular Formula | C11H17N5O2 |
Molecular Weight | 251.285 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dimethazan is a caffeine derivative. Dimethazan differs from caffeine by the replacement of the third methyl group. Dimethazan possesses antidepressant and diuretic properties. Dimethazan, administered intravenously to geriatric patients, produced respiratory and cerebral stimulation in the majority of cases. The clinical utilization of the respiratory stimulatory effect was confirmed in a patient markedly depressed with chlorpromazine. Oral administration to patients hospitalized for treatment of mental and physical depression indicated a dual effect: central nervous system stimulation and sedation. It is safe and well tolerated with none of the shortcomings of other caffeine preparations.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13559232
50 to 600 mg over a 2- to 4-minute period
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:27:02 GMT 2023
by
admin
on
Fri Dec 15 17:27:02 GMT 2023
|
Record UNII |
H943V308AD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m696
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000082661
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
208-266-1
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
10612
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
3731
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
519-30-2
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
Dimethazan
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
DTXSID10199858
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
SUB07171MIG
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL1739955
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
H943V308AD
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
C169911
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY | |||
|
778
Created by
admin on Fri Dec 15 17:27:02 GMT 2023 , Edited by admin on Fri Dec 15 17:27:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |